guidesApril 4, 2026·6 min read

Tirzepatide Reconstitution: 5mg + 2mL Chart

Most mixing errors happen at the syringe math step. Step-by-step with dilution charts for 5mg, 10mg, and 15mg vials plus storage rules.

Tirzepatide Reconstitution Guide

How to Reconstitute Tirzepatide

Research-grade tirzepatide arrives as a lyophilized (freeze-dried) powder, typically in 5mg, 10mg, or 15mg vials. Before it can be injected, you need to reconstitute it with bacteriostatic water. The process is straightforward, but the dose escalation protocol from 2.5mg to 15mg weekly makes your dilution choice critical.

Get this wrong and you're either injecting too much volume or struggling to measure tiny amounts on a syringe. This guide covers the full mixing process, dilution math for all three vial sizes, and proper storage.

What You Need

Before you start, gather everything:

  • Tirzepatide lyophilized vial (5mg, 10mg, or 15mg)
  • Bacteriostatic water (BAC water) -- not sterile water, not saline
  • Insulin syringes -- 1mL (100 unit), 29-31 gauge
  • Alcohol swabs -- for cleaning vial tops
  • A clean, flat workspace

Why bacteriostatic water? It contains 0.9% benzyl alcohol that prevents bacteria from growing in your solution. Regular sterile water has no preservative, so the vial must be used within 24 hours. Since tirzepatide is dosed once weekly and a single vial can last weeks, BAC water is essential -- it gives you up to 28 days refrigerated.

Step-by-Step Reconstitution

Step 1: Clean Everything

Wipe the tops of both vials (tirzepatide and BAC water) with alcohol swabs. Let them air dry for 10 seconds. This prevents contamination.

Step 2: Draw Your Bacteriostatic Water

Using a fresh insulin syringe, draw your desired amount of BAC water. The amount you add determines your concentration (see the dilution charts below).

For a 10mg vial, 2mL is the sweet spot. It gives you 5,000mcg/mL -- clean numbers across the entire dose escalation from 2.5mg through 15mg.

Step 3: Add Water to the Peptide Vial

Insert the needle into the tirzepatide vial at an angle, aiming at the glass wall -- not directly at the powder. Let the water trickle down the side of the vial gently.

Do not squirt water directly onto the powder. Tirzepatide is a 39-amino-acid peptide with a C20 fatty diacid chain. Aggressive mixing can damage the molecular structure and reduce potency. Spray the water down the inside wall and let it flow onto the powder naturally.

Step 4: Let It Dissolve

Gently swirl the vial with a slow rotating motion. Do not shake it. The powder should dissolve within 1-2 minutes into a perfectly clear, colorless solution.

If particles remain after 5 minutes of gentle swirling, the peptide may be degraded. A properly manufactured tirzepatide dissolves easily.

Step 5: Store Correctly

Refrigerate immediately at 36-46F (2-8C). The reconstituted solution is stable for up to 28 days with bacteriostatic water.

Dilution Charts

Tirzepatide Dilution Steps

Why 2mL for a 10mg vial? It keeps every dose in the standard escalation protocol measurable on a standard insulin syringe. At 2mL in a 10mg vial, a 2.5mg starting dose is exactly 50 units and a 5mg dose is exactly 100 units -- no awkward fractions.

Syringe Math

Here's the formula for any vial size and any amount of water:

Concentration = Peptide Amount (mcg) / Water Added (mL)

Then to find your injection volume:

Units to inject = Desired Dose (mcg) / Concentration (mcg/mL) x 100

Example: 10,000mcg vial + 2mL water = 5,000mcg/mL. For a 2.5mg (2,500mcg) dose: 2,500 / 5,000 x 100 = 50 units.

For a 5mg dose: 5,000 / 5,000 x 100 = 100 units -- the full syringe.

Doses Per Vial

5mg vial:

  • At 2.5mg/week = 2 weeks
  • At 5mg/week = 1 week

10mg vial:

  • At 2.5mg/week = 4 weeks
  • At 5mg/week = 2 weeks
  • At 7.5mg/week = 1.3 weeks
  • At 10mg/week = 1 week

15mg vial:

  • At 2.5mg/week = 6 weeks
  • At 5mg/week = 3 weeks
  • At 10mg/week = 1.5 weeks
  • At 15mg/week = 1 week

A 10mg vial covers the first month of a standard escalation at 2.5mg/week. At maintenance doses of 10-15mg, plan on one vial per week.

Don't want to do math? Use our Reconstitution Calculator -- plug in your vial size, water amount, and desired dose, and it does the rest.

Best Doctor-Guided Tirzepatide Programs

Storage Rules

State Temperature Shelf Life
Lyophilized (powder) Room temp 6-12 months
Lyophilized (powder) Refrigerated 2+ years
Lyophilized (powder) Frozen (-20C) 3+ years
Reconstituted (BAC water) Refrigerated Up to 28 days
Reconstituted (sterile water) Refrigerated Use within 24 hours

Key rules: Refrigerate immediately after reconstitution. Keep the vial upright and away from light. Pull the vial out, draw your dose, and put it back -- don't leave it on the counter.

Tirzepatide Storage Guide

Pro tip: If you buy multiple vials, keep unopened ones in the freezer and only reconstitute what you'll use within 3-4 weeks.

Common Mistakes

Spraying Water Directly onto the Powder

This is the single most common error. Directing the stream onto the lyophilized cake can damage the peptide through mechanical shearing. Always aim at the glass wall and let the water trickle down.

Shaking the Vial

Peptides are proteins. Shaking creates foam, trapping air bubbles against peptide molecules at the air-liquid interface. This can denature (destroy) the peptide. Always swirl gently.

Using Too Little Water

Adding 0.5mL to a 10mg vial gives you 20,000mcg/mL. That makes a 2.5mg dose only 12.5 units -- measurable but leaves no room for error. Worse, higher doses exceed a single syringe. Use at least 2mL for a 10mg vial.

Not Planning for Dose Escalation

Tirzepatide protocols escalate from 2.5mg to 15mg weekly over months. If you reconstitute with too much water, higher doses require multiple syringe draws. At 2mL per 10mg vial, every dose from 2.5mg to 10mg fits in one draw. For 15mg doses, use a 15mg vial with 3mL.

Leaving It at Room Temperature

Reconstituted tirzepatide degrades above refrigerator temperature. Every hour at room temperature reduces potency. Draw your dose and refrigerate immediately.

References

  1. Jastreboff, A.M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(4), 327-340. PMID:35658024
  2. Frias, J.P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. PMID:34170647
  3. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). The Lancet, 398(10295), 143-155. PMID:34186022
  4. Min, T., & Bain, S.C. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes. Expert Review of Endocrinology & Metabolism, 17(6), 473-483. PMID:36050763
  5. USP General Chapter 797: Pharmaceutical Compounding -- Sterile Preparations. Storage and beyond-use dating guidelines for reconstituted peptides.

This guide is for educational and informational purposes only. It is not medical advice. Research-grade tirzepatide is sold as a research compound. Reconstituting and self-administering peptides carries inherent risks including infection, contamination, and dosing errors. Always use proper sterile technique. Consult a qualified healthcare provider before starting any peptide protocol. The Peptide Catalog is not responsible for any adverse effects resulting from the use or misuse of information presented here.